TIETOJA TÄSTÄ PODCASTISTA 🔗

Päivitä taajuus:
every 10 days
Keskimääräinen äänen pituus:
48 minutes
Vierashaastattelut
Englanti
Yhdysvallat
18 jaksoa
vuodesta 17. huhtikuuta 2026
episodic

VIIMEISIN JAKSO 🔗

In a recent episode of “Brain Trust: Conversations in Psychopharmacology,” host Joseph F. Goldberg, MD, spoke with Jonathan M. Meyer, MD, voluntary clinical professor of psychiatry at the University of California, San Diego, about therapeutic drug monitoring of antipsychotics in schizophrenia spe…

HAE EDELLISIÄ EPISODEJA

Hae kanavan Brain Trust: Conversations in Psychopharmacology vanhoja jaksoja.

EDELLISET JAKSOT

In this “Brain Trust Conversations in Clinical Psychopharmacology” episode, host Joseph F. Goldberg, MD, spoke with Anita Clayton, MD, who is the Wolford Spratlin professor and past chair of psychiatry and neurobehavioral sciences at the University of Virginia and current president of the America…
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Carl Salzman, MD, to discuss the appropriate clinical use, misuse, and safety of benzodiazepines, including special considerations for older adults and their debated association with …
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sat down with Walter Brown, MD, to discuss the placebo effect in clinical psychopharmacology, including its mechanisms, the nocebo effect, ethical considerations, and practical strategies for harnes…
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sat down with Michael Ostacher, MD, MPH, to discuss managing co-occurring mood and substance use disorders (SUDs), including patient engagement, the "self-medication" narrative, and underuse of evid…
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Roy Perlis, MD, to discuss the role of artificial intelligence (AI) in clinical psychopharmacology, including its applications in treatment-resistant depression (TRD), suicide risk st…
Joseph F. Goldberg, MD, in this special installment of "Brain Trust: Conversations in Psychopharmacology," sat down with a panel of experts from the American Society of Clinical Psychopharmacology Annual Meeting (ASCP) Deprescribing Task Force while in attendance at the 2026 ASCP Annual Meeting i…
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with David Dunner, MD, FACPsych, to discuss practical insights into the evolving treatment of bipolar disorder and treatment-resistant depression. Dunner described the origins of the rapid…
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Martha Sajatovic, MD, to discuss the multifaceted challenge of medication adherence in psychiatric practice. Sajatovic opened by framing adherence as behavioral and attitude alignment…
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Henry Nasrallah, MD, to discuss off-label prescribing and polypharmacy. Nasrallah bases the discussion off his landmark analysis that demonstrated 88% of DSM psychiatric diagnoses hav…
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin Brain Trust: Conversations in Psychopharmacology:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.